pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
risvutatug rezetecan · news · pharmadog
← back to risvutatug rezetecan
News mentioning risvutatug rezetecan
12
stories
13d
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
biospace
13d
Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal
fiercebiotech
26d
GSK bags Chimagen’s trispecific T cell engager in deal worth up to $750M
biospace
26d
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
biospace
27d
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
biospace
Sep 11, 26
GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
fiercebiotech
Jul 28, 26
GSK shares rise as $2.5B cost-cutting plan unveiled
biospace
Jul 28, 26
GSK partner Hansoh reports another phase 3 win for priority ADC
fiercebiotech
Jul 23, 26
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
biospace
Jul 10, 26
GSK, Hansoh ADC extends survival in lung cancer study
biopharma dive
Jul 10, 26
Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injector
endpoints
Jun 9, 26
GSK boosts cancer pipeline with $11B Nuvalent buyout
biopharma dive
